MedTrace Logo

Immunological Profile Changes In Patients With Advanced Non-Small Cell Lung Cancer

NCT04187768 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29

Last updated 2022-07-20

No results posted yet for this study

Summary

This is a blood collection study being conducted to better understand and describe the immunological blood profile changes in patients with advanced non small cell lung cancer undergoing treatment with checkpoint inhibitor therapy. Blood will be collected from healthy volunteers and patients with non small cell lung cancer

Conditions

  • Non Small Cell Lung Cancer
  • Non Small Cell Lung Cancer Metastatic
  • Healthy

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Nasser Hanna, MD · Indiana Unversity

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-26
Primary Completion
2022-06-13
Completion
2022-06-13

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04187768 on ClinicalTrials.gov